Lee DC, Schlienz NJ, Herrmann, ES, Martin EL, Leoutsakos J, Budney AJ, Smith MT, Tompkins DA, Hampson AJ, Vandrey R. Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder. J Subst Abuse Treat. 2024; 156: 209180.

Lee, D. C., Schlienz, N. J., Peters, E. N., Dworkin, R. H., Turk, D. C., Strain, E. C., & Vandrey, R. (2019). Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug and alcohol dependence, 194, 500-517.

Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.Drug Alc Depend. 2017; 177; 249-257. 

Herrmann ES, Weerts E, Vandrey R. Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users. Expand Clin Psychopharm. 2015; 23; 415-421.

Schlienz NJ, Lee DL, Stitzer ML, Vandrey R. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Drug Alc Depend. 2018; 187; 254-260.

Thrul J, Gubner NR, Nguyen N, Nguyen C, Goodell EA, Holmes LM, Vandrey RG, Ling PM. Perceived reward from using cigarettes with alcohol or cannabis and concurrent use: A smartphone-based daily diary study. Addictive Behaviors. 2021; 114; 106747.

Spindle TR, Kuwabara H, Eversole A, Nandi A, Vandrey R, Antoine DG, Umbricht A, Guarda AS, Wong DF, Weerts EM. Brain Imaging of Cannabinoid Type I (CB1) Receptors in Women with Cannabis Use Disorder and Male and Female Healthy Controls. Addict Biol.  26(6) 2021, e13061 OPEN ACCESS. https://doi.org/10.1111/adb.13061

Lee, D.C. et al. Randomized controlled trial of Zolpidem as a pharmacotherapy for cannabis use disorder. Journal of Substance Use and Addiction Treatment, 156, p. 209180. 2024. doi:10.1016/j.josat.2023.209180